1) "counseled by several industry veterans" What industry

New Post Public Reply Private Reply Replies (3) Message Board
gobears1985 longboardsurfer90210 #21252
Quote:
1) "counseled by several industry veterans" What industry veterans? He needs counseling?
Do you expect him to name names? I also don't think you understand the word counsel in this context.

2) "chief among them being patience and faith." Part of the counseling he received was an industry veteran telling him to be patient and that it takes time? Really?
I'm not getting your point. I think there are a lot of examples of patience being important and development taking time

3) "current team." You mean, whats left of the current team?
Just because a few people have left doesn't mean there is nobody left.

4) "while also delivering significant value to a healthcare system stretched to its financial capacity.” Yeah, that’s what he is concerned about.
Non-issue. Not worth commenting on. You're just nit-picking here.

5) "near-term liquidity events." Ahh- the ever so elusive near term event.
Ever so elusive until it happens, then it's not elusive anymore. It only takes one.

6) "the Board of Directors has given management the mandate to accelerate our partnering initiatives in order to acquire the resources necessary to move the rest of the portfolio forward. " Oh, so the reason we don’t have any partners for ANY OF OUR ASSETS is because management never forced us to consider them?
He said they have given the mandate to accelerate the partnering initiatives, not that they haven't ever considered it before. Also, they have more assets to partner now than they used to have.

7) "while preserving and/or transferring value to our shareholders along the way." This statement needs zero comment.
You're not providing the context of the quote. He's talking about shareholder value increasing if they partner an asset, which is obvious. So yes, there is no comment needed.

8) " transact on either ESS or Eltoprazine in order to further refine the Company’s profile into a regenerative medicine company (ESS + MANF + Phenoguard) or a neurology company (Eltoprazine + MANF + Phenoguard)" In other words, we have no idea who we are or what we are about. And what the hell does “transact on” mean?
Sell or partner. Read it carefully. If we sell ESS, we keep Elto. If we sell Elto, we keep ESS. It's not about not knowing who we are. It's about our options after we sell one of the assets involved.

9) "could provide a pipeline for a very valuable standalone public company." There is the elusive “could provide” but hasn’t yet, but keep holding your breath.
If it was already provided, this blog would not have been necessary because we'd all be rich. Just because it hasn't happened, doesn't mean it can't happen.

10) "conditions in the market for our common shares rapidly deteriorated in the third quarter." -It just gets better. Conditions in the market didn’t deteriorate the value, getting into bed with toxic financiers did. This was the one I was REALLY hoping to not hear. The CEO is directly responsible for the deterioration of the share price….PERIOD! Nice try Gerald, by passing the buck.
Discounting the market conditions and placing 100% of the blame on the CEO is ludicrous. I'm not saying the market conditions were 100% of the problem either, but no one person or situation is 100% responsible.

11) "value appreciation of our common stock could potentially occur." – Again, been hearing that for the last 3 years.
Just because it hasn't happened doesn't mean it can't happen

12) "As we evaluate potential business development opportunities." What potential business development opportunities do they have to evaluate? Been hearing this one forever. Must be attached to those ever elusive NDA’s.
Good question on your part. If you really expect specific details, you don't know how things work.

13) "we are working behind the scenes to understand." – In other words, “ we don’t know what’s going on.” That’s a great place to be after destroying all of the long term shareholders value.
Stop taking quotes out of context. He's referring to their course of action regarding the ODD pathway for Elto. It's likely they don't know yet, which is entirely reasonable.

14) "begin evaluating Phase 3 development plans for adult ADHD as well as Phase 2 development plans for Alzheimer’s aggression." - “Begin evaluating”? Means nothing.
You have to plan before you can start a trial.

15) "Given the recent uptick in interest in Alzheimer’s therapies" – Recent? The interest in Alzheimers therapies is not “recent”.
I think he's referring to AVXL here.

16) "we are especially excited about the potential to develop Eltoprazine in this area" – Ahhhhh. The overly used “especially excited”.
Nit-picking again. Do you want him to say they are not excited?

17) "made good progress on the commercial launch plan for MSPrecise® at a meeting we held in Dallas, TX." Ahhhh, the overly used “made good progress” statement. Meeting with who? Who wants MS Precise? We have had it for how long?
You're not going to find this out until it's sold.

18) " continuing to evaluate the next set of studies to further enhance LymPro’s value - Ahhhh, the “continuing to evaluate” statement. I thought this thing was going to be generating revenue so that we would not have to dilute. Besides, “a reverse split may not even be necessary.”
Go back to the Lympro blog by Dr. Trzepacz and refresh your memory

19) "and will forego the option agreement with Georgetown University." – Hence, “we have no more money to continue with our option agreement.” I thought this was necessary to strengthen the diagnostics suite and increase the accuracy of the Lympro test?
They are studying Lympro in conjuction with PET. I don't think they want to put money into advancing G'town if they are going to sell Lympro off in the near future.

20) "that we recently completely enrollment." - A fricken spelling error? Does not anyone re-read these things before they post them?
This time, I agree with you. That bugs me.

21) "we believe we have sufficient critical mass." – And again the “we believe”. Obviously the market does not share your belief.
The market doesn't believe until it does believe. It doesn't mean it won't happen

22) "are now focused on the CLIA launch plans for these products. – I thought this was going to happen ages ago. “Now focused”?
Plans change.

23) "We remain on track to transact on the diagnostics division"- Really? Remain on track? That’s a subjective term. For when? 2030?
STOP QUOTING PORTIONS OF SENTENCES. Literally, the next words were "in the fourth quarter." Geez.

24) "as a key time to potentially make public announcements of definitive agreements." – This is the best. “Potentially make” and “definitive agreements” used in the same sentence.
He can't say exactly when announcements will come if he doesn't know when agreements will be final. At least he gives a ballpark estimate of a date and time.

25) "we believe the sheer strength of our portfolio will allow the Company to overcome the challenges we face." – Yeah, its doing such a good job so far. The only challenge we need to overcome is to figure out how to get someone in there that knows what they are doing.
GC's not going anywhere so you might as well stop thinking about it.

26) "we believe we have a strong execution plan, with achievable milestones" – “Believe”? How about “know”? Also, heard this many times in the past.
Semantics. Nit-picking again.

27)"We believe the support of our shareholders at this time in our corporate history is paramount." – This one takes the trophy! And we should support you because? Based on this piece of crap blog? Based on all of things you have claimed that never happened? Your stellar communication? It’s as if he does not even realize that many of us are down 90% +. He has given us zero reason to support his, what I now consider, delusional visions.
Then don't support them and sell your shares. Easy solution.

28) "working with our team" – what team? Who is left?
I already responded to this one earlier. See #3.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 466

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 223

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 335

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 246

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Geotab's Vision for Addressing Youth Unemployment Through Internships

Updated Category News Views 169

Geotab's Commitment to Future Workforce Development As Geotab Inc. celebrates its remarkable 25th anniversary, the company is taking bold steps to enhance internship opportunities for young graduates entering an increasingly competitive job market. With youth unemployment rates rising in North America, organizations like Geotab are not only addressing a pressing social...

Continue Reading
Joaquín de Valenzuela Joins nCino as EMEA Managing Director

Updated Category News Views 90

Joaquín de Valenzuela Takes the Helm at nCino for EMEA nCino, Inc. (NASDAQ: NCNO), a leader in intelligent banking solutions, is proud to announce the appointment of Joaquín de Valenzuela as the Managing Director for the EMEA region. This significant hire underscores the company's dedication to bolstering its growth trajectory and expanding its influence across the...

Continue Reading
Aya Gold & Silver Unveils Stunning Silver Drilling Results

Updated Category News Views 123

Aya Gold & Silver Reports New Silver Drilling Success Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) is excited to share outstanding silver drill results from its ongoing exploration at the Zgounder Silver Mine. The results not only highlight high-quality silver finds but also identify several promising new targets in the Zgounder Regional area. Drilling Highlights and...

Continue Reading
Nvidia's Deep Roots in China's Tech Landscape Drive AI Success

Updated Category News Views 278

Nvidia's Deep Roots in China's Tech Landscape Drive AI Success Nvidia Corp. CEO Jensen Huang recently highlighted the significant impact of China’s technology ecosystem on Nvidia’s growth during a keynote address at a major university event. His reflections underline a robust relationship spanning over 25 years, which has been pivotal in shaping Nvidia into a leading...

Continue Reading
Aalberts N.V. Achieves Strategic Growth Despite Market Challenges

Updated Category News Views 314

Aalberts N.V. Reports First Quarter Results In the latest financial report, Aalberts N.V. showcased its first quarter outcomes, revealing revenues of EUR 778.3 million. This figure marks a 3.3% decline in organic revenue compared to the same period last year, pointing to ongoing challenges within the market. Operational Performance and Margin Insights The company's EBITA...

Continue Reading